Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome
第一作者:Weihua Jia
通讯作者:Yongjun Wang
2015-04-01
It is unclear whether postthrombolytic antiplatelet (AP) therapy after thrombolytic-related hemorrhage without extensive parenchymal involvement (THEPI) a!ects the clinical outcome. "is study explored whether AP administration in patients with THEPI a!ects short- and long-term outcomes.